Avid Bioservices' stockholders approve transaction with GHO and Ampersand
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 30 2025
0mins
Should l Buy ?
Stockholder Approval: Avid Bioservices' stockholders have approved the transaction with GHO Capital Partners and Ampersand Capital Partners during a special meeting.
Transaction Closure: With regulatory approvals in place, Avid expects to finalize the transaction in the coming days, providing immediate cash value to its stockholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
